Drug Producers Can not Finish Opioid Trial In California, Decide Guidelines

Law360 (June 15, 2021, 6:43 p.m. EDT) – A California judge Tuesday denied efforts by drug manufacturers to end a landmark opioid degree in which Golden State communities claim the marketing of narcotic pain relievers is an addiction epidemic caused.

Orange County’s Supreme Court ruling, Peter J. Wilson, upheld claims that divisions of Johnson & Johnson, Endo Pharmaceuticals, Teva Pharmaceuticals and Allergan PLC created a “public nuisance” in the form of the opioid crisis. The decision followed oral arguments on the drug manufacturers’ motions in their favor after the municipalities suspended their case nearly two months after the trial began.

“The court refuses to judge the claims …

Stay ahead of the curve

In the legal profession, information is the key to success. You need to know what is happening to customers, competitors, practice areas and industries. Law360 offers the intelligence you need to stay an expert and beat the competition.

  • Access case data within articles (numbers, filings, courts, type of lawsuit, and more.)
  • Access to attached documents such as Briefs, petitions, complaints, decisions, motions, etc.
  • Create custom notifications for specific article and case topics and much more!

TRY THE LAW360 FREE SEVEN DAYS

Comments are closed.